免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Lumpipulse G CA19-9-N

K号: K191973 · 2019-10-22

决定日期2019-10-22
产品代码NIG
咨询委员会抱歉,您提供的信息不完整,无法进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Lumpipulse G CA19-9-N is the device name listed in this FDA 510(k) record. The listed applicant is Fujirebio Dianostics, Inc.. It received FDA 510(k) clearance on 2019-10-22 under 510(k) number K191973. The device is classified under product code NIG. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Lumpipulse G CA19-9-N?

Lumpipulse G CA19-9-N is a medical device that received FDA 510(k) clearance on 2019-10-22. The listed applicant is Fujirebio Dianostics, Inc.. The 510(k) number is K191973.

When did Lumpipulse G CA19-9-N receive FDA 510(k) clearance?

Lumpipulse G CA19-9-N received FDA 510(k) clearance on 2019-10-22, under 510(k) number K191973.

Who is the listed applicant for Lumpipulse G CA19-9-N?

The FDA 510(k) record lists Fujirebio Dianostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lumpipulse G CA19-9-N?

The FDA product code for Lumpipulse G CA19-9-N is NIG.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NIG)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑